Tenet Healthcare (NYSE:THC) is scheduled to challenge its quarterly earnings information soon after the industry closes on Monday, November 4th. Analysts count on the corporation to announce earnings of $.28 per share for the quarter. Parties that are interested in registering for the company’s conference get in touch with can do so making use of this hyperlink.
Tenet Healthcare (NYSE:THC) final issued its quarterly earnings information on Monday, August 5th. The corporation reported $.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $.44 by $.12. The firm had income of $four.56 billion throughout the quarter, compared to analysts’ expectations of $four.48 billion. Tenet Healthcare had a good return on equity of 28.95% and a damaging net margin of .09%. Tenet Healthcare’s income was up 1.two% on a year-more than-year basis. Throughout the identical period in the earlier year, the firm posted $.49 earnings per share. On typical, analysts count on Tenet Healthcare to post $two EPS for the present fiscal year and $three EPS for the subsequent fiscal year.
Shares of THC stock opened at $24.65 on Monday. The stock has a fifty day moving typical value of $23.01 and a 200 day moving typical value of $21.93. The stock has a industry cap of $two.58 billion, a PE ratio of 13.25, a P/E/G ratio of .67 and a beta of 1.62. Tenet Healthcare has a 1 year low of $16.60 and a 1 year higher of $31.64. The corporation has a debt-to-equity ratio of 19.96, a rapid ratio of 1.06 and a present ratio of 1.13.
THC has been the topic of quite a few analysis reports. ValuEngine raised Tenet Healthcare from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 2nd. Goldman Sachs Group initiated coverage on Tenet Healthcare in a report on Wednesday, August 14th. They set a “neutral” rating and a $28.00 value objective for the corporation. Royal Bank of Canada reaffirmed a “hold” rating and set a $26.00 value objective on shares of Tenet Healthcare in a report on Sunday, August 11th. Lastly, SunTrust Banks set a $24.00 value objective on Tenet Healthcare and gave the stock a “hold” rating in a report on Wednesday, August 7th. One particular equities analysis analyst has rated the stock with a sell rating, ten have assigned a hold rating and 3 have issued a obtain rating to the corporation. Tenet Healthcare at present has a consensus rating of “Hold” and an typical target value of $28.62.
In other Tenet Healthcare news, significant shareholder Glenview Capital Management, L acquired 221,875 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was acquired at an typical value of $20.50 per share, with a total worth of $four,548,437.50. The acquire was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed by means of the SEC web-site. Also, Director Edward A. Kangas sold 45,00 shares of Tenet Healthcare stock in a transaction on Wednesday, August 28th. The shares have been sold at an typical value of $20.28, for a total worth of $912,600.00. Following the completion of the sale, the director now straight owns 47,138 shares of the company’s stock, valued at roughly $955,958.64. The disclosure for this sale can be identified right here. Insiders have acquired 1,098,419 shares of corporation stock valued at $22,395,899 in the final 3 months. 1.50% of the stock is at present owned by corporation insiders.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare solutions corporation. The corporation operates in 3 segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its basic hospitals provide acute care solutions, operating and recovery rooms, radiology and respiratory therapy solutions, clinical laboratories, and pharmacies.
Featured Post: Understanding Compound Annual Development Price (CAGR)